| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |